# Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits

> **NCT06115070** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 390 (estimated)

## Conditions studied

- Thrombosis
- Acute Ischemic Stroke (AIS)

## Interventions

- **DRUG:** Intravenous thrombolysis (alteplase and other guideline-recommended thrombolytic agents)

## Key facts

- **NCT ID:** NCT06115070
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 390 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06115070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06115070, "Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06115070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*